Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform.

Signal transduction and targeted therapy·2026

Same author

Integrating PROTAC-based targeted protein degradation with nanodelivery systems to overcome cancer therapeutic resistance.

Advanced drug delivery reviews·2025

Same author

A Glutathione-Responsive System with Prodrug and Sensitization Strategies for Targeted Therapy of Glioma.

Small (Weinheim an der Bergstrasse, Germany)·2025

Same author

Current advance of nanotechnology in diagnosis and treatment for malignant tumors.

Signal transduction and targeted therapy·2024

Same author

Immunostimulatory CKb11 gene combined with immune checkpoint PD-1/PD-L1 blockade activates immune response and simultaneously overcomes the immunosuppression of cancer.

Bioactive materials·2024

Same author

Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy.

ACS nano·2024

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery.

MaLing Gou¹, XiaWei Wei, Ke Men

¹State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.

Current Drug Targets

|March 30, 2011

Summary

Biodegradable Poly(ε-caprolactone)/poly(ethylene glycol) (PCL/PEG) nanoparticles offer advanced cancer treatment delivery. These nanoparticles show potential for targeted drug delivery, gene therapy, and diagnostics.

More Related Videos

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Area of Science:

Biomedical Engineering
Materials Science
Oncology

Background:

Nanotechnology offers novel tools for cancer therapy.
Biodegradable polymeric nanoparticles are advanced drug delivery systems with cancer treatment applications.
Poly(ε-caprolactone)/poly(ethylene glycol) (PCL/PEG) copolymers are biodegradable, amphiphilic polymers suitable for drug delivery.

Purpose of the Study:

To review the application of PCL/PEG copolymeric nanoparticles as a nanoplatform for anticancer agent delivery.
To highlight the potential of PCL/PEG nanoparticles in overcoming challenges in cancer treatment delivery.

Main Methods:

Review of existing literature on PCL/PEG copolymer nanoparticles in cancer research.
Analysis of PCL/PEG nanoparticle properties for drug delivery applications.

Main Results:

PCL/PEG copolymer nanoparticles demonstrate potential for delivering hydrophobic drugs, overcoming their water insolubility.
These nanoparticles can be utilized for targeted delivery of chemotherapeutic agents to tumors.
PCL/PEG nanoparticles show promise for the delivery of genes, vaccines, and diagnostic agents.

Conclusions:

PCL/PEG copolymer nanoparticles represent a versatile platform for various cancer treatment modalities.
Further research into PCL/PEG nanoparticles can advance targeted cancer therapy and diagnostics.